Literature DB >> 23352507

5-AIQ inhibits H2O2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3β signaling pathway in H9c2 cardiomyocytes.

Eun-Seok Park1, Jun Chul Kang, Do-Hyun Kang, Yong Chang Jang, Kyu Yang Yi, Hun-Jong Chung, Jong Seok Park, Bokyung Kim, Zhong-Ping Feng, Hwa-Sup Shin.   

Abstract

Poly(adenosine 5'-diphosphate ribose) polymerase (PARP) is a nuclear enzyme activated by DNA strand breaks and plays an important role in the tissue injury associated with ischemia and reperfusion. The aim of the present study was to investigate the protective effect of 5-aminoisoquinolinone (5-AIQ), a PARP inhibitor, against oxidative stress-induced apoptosis in H9c2 cardiomyocytes. 5-AIQ pretreatment significantly protected against H2O2-induced cell death, as determined by the XTT assay, cell counting, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, and Western blot analysis of apoptosis-related proteins such as caspase-3, Bax, and Bcl-2. Upregulation of antioxidant enzymes such as manganese superoxide dismutase and catalase accompanied the protective effect of 5-AIQ on H2O2-induced cell death. Our data also showed that 5-AIQ pretreatment protected H9c2 cells from H2O2-induced apoptosis by triggering activation of Akt and glycogen synthase kinase-3β (GSK-3β), and that the protective effect of 5-AIQ was diminished by the PI3K inhibitor LY294002 at a concentration that effectively abolished 5-AIQ-induced Akt and GSK-3β activation. In addition, inhibiting the Akt/GSK-3β pathway by LY294002 significantly attenuated the 5-AIQ-mediated decrease in cleaved caspase-3 and Bax activation and H9c2 cell apoptosis induction. Taken together, these results demonstrate that 5-AIQ prevents H2O2-induced apoptosis in H9c2 cells by reducing intracellular reactive oxygen species production, regulating apoptosis-related proteins, and activating the Akt/GSK-3β pathway.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352507     DOI: 10.1016/j.taap.2013.01.004

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Effects of microRNA-139 on myocardial cell injury induced by oxidative stress.

Authors:  Tao Li; Sumei Liang; Yuxiu Zhang; Yongqing Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Identification of cardioprotective agents from traditional Chinese medicine against oxidative damage.

Authors:  Jian-Ming Zhou; Zhi-Liang Xu; Na Li; Yi-Wu Zhao; Zhen-Zhong Wang; Wei Xiao
Journal:  Mol Med Rep       Date:  2016-05-11       Impact factor: 2.952

3.  Characteristics of Chinese herbal medicine usage in ischemic heart disease patients among type 2 diabetes and their protection against hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts.

Authors:  Fuu-Jen Tsai; Tsung-Jung Ho; Chi-Fung Cheng; Yi-Tzone Shiao; Wen-Kuei Chien; Jin-Hua Chen; Xiang Liu; Hsinyi Tsang; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Ju-Pi Li; Cheng-Wen Lin; Jaung-Geng Lin; Yu-Ching Lan; Yu-Huei Liu; Chien-Hui Hung; Jung-Chun Lin; Chih-Chien Lin; Chih-Ho Lai; Wen-Miin Liang; Ying-Ju Lin
Journal:  Oncotarget       Date:  2017-02-28

4.  Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.

Authors:  Wei Wu; Xingxing Liu; Longfei Han
Journal:  Biosci Rep       Date:  2019-01-03       Impact factor: 3.840

5.  Matrine Exerts Hepatotoxic Effects via the ROS-Dependent Mitochondrial Apoptosis Pathway and Inhibition of Nrf2-Mediated Antioxidant Response.

Authors:  Longtai You; Chunjing Yang; Yuanyuan Du; Yi Liu; Gongsen Chen; Na Sai; Xiaoxv Dong; Xingbin Yin; Jian Ni
Journal:  Oxid Med Cell Longev       Date:  2019-10-14       Impact factor: 6.543

6.  Regulation of the Keap1-Nrf2 Signaling Axis by Glycyrrhetinic Acid Promoted Oxidative Stress-Induced H9C2 Cell Apoptosis.

Authors:  Zhangyu Jiang; Yanqing Wang; Xiuli Xi; Weibin Cai; Changhui Liu; Ran Ye; Liu Yang; Song Zhang; Rong Zhang; Qin Xu; Lei Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-27       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.